Skip to main content

Table 4 Lung Function parameters in the first survey and annual changes (mean and C.I. 95%) adjusted for height and gender with multiple regression analysis

From: Lung function changes from childhood to adolescence: a seven-year follow-up study

  

2003

Δ/year

P<

  

Mean

Mean

model

(C.I.)

(C.I.)

FEV 1 (ml)

No symptoms

1108.8

181.9

NS

(1087.6-1129.9)

(176.0 -187.9)

Early transient

1122.3

186.9

(1032.2-1212.4)

(161.8 - 212.1)

Late onset

1105.7

171.5

(1045.31 -166.0)

(154.6 - 188.4)

Persistent

1100.2

172.0

(1030.5 - 1169.9)

(152.4 - 191.5)

FVC (ml)

No symptoms

1121.4

233.8 (228.4 - 239.3)

NS

(1100.6 - 1142.1)

Early transient

1159.3

232.2

(1072.7-1245.8)

(208.4 - 255.9)

Late onset

1134.6

229.0

(1072.3 - 1197.0)

(212.5 - 245.4)

Persistent

1151.5

234.9

(1074.3 - 1228.7)

(214.5 - 255.4)

FEV 1 /FVC (%)

No symptoms

96.5

−1.5

*

(95.9 - 97.2)

(−1.7 - -1.4)

Early transient

94.2

−1.1

(91.5 - 97.0)

(−1.7 - -0.6)

Late onset

96.7

−1.8

(94.9 - 98.5)

(−2.2 - -1.4)

Persistent

95.9

−2.0 *

(93.8 - 98.0)

(−2.4 - -1.6)

FEF 25–75 (ml/s)

No symptoms

1621.9

157.4

***

(1580.6 - 1663.1)

(146.8 - 168.0)

Early transient

1531.5

158.6

(1353.4 - 1709.6)

(113.0 - 204.1)

Late onset

1570.3

135.5 *

(1447.4 - 1693.1)

(104.0 - 166.9)

Persistent

1506.4

113.7 **

(1354.2 - 1658.6)

(74.7 - 152.7)

  1. - * P < 0.05.
  2. - ** P < 0.01.
  3. Δ: (Differences between the 2 occasions/Years of follow-up)
  4. Note: the statistical significativity in the last column is for the model; the * in the cell reports the significativity of the difference of the mean compared with the asymptomatic subjects mean.